Cencora Inc (COR)

Industry Medical Distribution

This stock can be held in an Investment ISA and an Investment Account

Sell

$338.79

Buy

$347.25

arrow-up$1.50 (+0.44%)

Prices updated at 12 Dec 2025, 23:46 EST

Prices minimum 15 mins delay

Prices in USD

AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Distribution

Chairman

Mr. Dermot Mark Durcan

CEO

Mr. Robert P. Mauch

Most recent earnings

30 Sep 2025

Fiscal year end

30 Sep 2025

Employees

51,000

Head office

1 West First Avenue

Conshohocken

United States

19428-1800

+1 610 727-7000

bennett.murphy@cencora.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Dermot Mark Durcan Chairman of the Board	0.13m
Mr. Lon R. Greenberg Independent Director	0.12m
Ms. Lori J. Ryerkerk Independent Director	-
Mr. James F. Cleary, Jr Executive Vice President and Chief Financial Officer	0.89m
Mr. Werner Baumann Independent Director	0.15m
Mr. Lazarus Krikorian Senior Vice President and Chief Accounting Officer	-
Mr. Robert P. Mauch Director, President and Chief Executive Officer	1.04m
Dr. Lorence H. Kim, M.D. Independent Director	0.12m
Mr. Pawan Verma Executive Vice President and Chief Data and Information Officer	-
Mr. Dennis M. Nally Independent Director	0.18m
Mr. Frank K. Clyburn, Jr Independent Director	-
Ms. Lauren M. Tyler Independent Director	0.14m
Ms. Silvana Battaglia Executive Vice President and Chief Human Resources Officer	0.63m
Ms. Elizabeth S. Campbell Executive Vice President and Chief Legal Officer	0.72m
Dr. Redonda G. Miller, M.B.A. Independent Director	0.15m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	22,479,041
BlackRock Inc	19,777,491
JPMorgan Chase & Co	9,355,594
State Street Corp	9,190,316
T Rowe Price Associates, Inc	8,781,914

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2024	-
31 Dec 2024	-
20 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
18 Dec 2024	-
03 Dec 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
25 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.